Bristol Myers Slumps After Its Heart Condition Study Gets The Boot

investors.com/news/technology/bristol-myers-squibb-acute-coronary-syndrome-study

Shares of Bristol Myers Squibb slumped Friday after the company scrapped a study testing a treatment for acute coronary syndrome.
The post Bristol Myers Slumps After Its Heart Condition Study Gets The Boot appeared first on Investor's Business Daily.

This story appeared on investors.com, 2025-11-14 14:38:04.
The Entire Business World on a Single Page. Free to Use →